Solvay refocuses on specialty materials, shares tracked against European chemicals peers

By Thomas Klein, Operations & Strategy desk. Reviewed prior to publication on 2026-06-26, 14:48.

Solvay (BE0003470755) continues to reshape its portfolio as it approaches the full separation of its commodity and specialty businesses. The Brussels-based chemicals group is increasingly compared with European peers BASF and Arkema in investor discussions, especially on Euronext Brussels and other continental venues.

What recent disclosures show

Solvay completed the spin-off of its bulk chemicals business into Syensqo at the end of 2023, and the two companies now publish separate financials, capital allocation policies and strategic roadmaps per their investor presentations. The company’s investor relations material highlights a stronger focus on higher-margin specialty materials, advanced formulations and sustainability-linked solutions in the remaining Solvay perimeter.

Management has repeatedly underlined ambitions for structurally higher returns on capital in specialty businesses compared with legacy commodity activities, according to recent Solvay capital markets day documentation and sector commentary from houses such as UBS and Deutsche Bank. Reuters previously described the transaction as part of a broader European chemicals trend toward portfolio simplification and value-accretive separations.

How analysts view the stock

Coverage by major European research houses such as UBS, Deutsche Bank and Berenberg typically highlights Solvay’s exposure to end-markets including batteries, automotive light-weighting and electronics, where specialty polymers and materials can support pricing power and volume resilience across cycles. Consensus compiled on platforms like MarketScreener and FactSet points to a mixed but generally constructive stance, with a distribution of ratings between Buy, Hold and a smaller number of Sell recommendations. Consensus data on Solvay show target prices that place the group broadly in line with or at a premium to traditional diversified peers in price-to-earnings and EV/EBITDA terms.

Analyst notes often compare Solvay’s strategic positioning with BASF, Evonik and Arkema, particularly in areas such as battery materials and specialty polymers, with attention on capital expenditure, research and development intensity and decarbonization plans. Handelsblatt has analyzed the separation and its implications for margins and valuation, highlighting the shift toward more specialized, less commoditized activities.

Where Solvay earns its money

Solvay generates a significant share of its revenue from specialty polymers and advanced materials used in sectors such as electric vehicle batteries, aerospace composites and high-performance electronics. Product families like its Solef PVDF polymers and high-temperature specialty plastics are marketed for applications that demand durability, chemical resistance and light weight, according to Solvay’s product documentation and investor materials.

Where the shares trade today

Solvay shares (BE0003470755) trade on Euronext Brussels; at the time of the latest available quote from the exchange, the stock was changing hands at a price in euros consistent with its placement among European chemicals peers, based on data from Euronext and major financial portals.

This article is for informational purposes only and does not constitute investment advice or a solicitation to buy or sell any securities. Investors should conduct their own research and consider their individual financial situation before making investment decisions.